Seascape Clinical — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Seascape Clinical offers a specialized software-as-a-service (SaaS) platform designed to solve the operational inefficiencies faced by clinical trial sponsors. The company targets a critical pain point: the fragmented and manual oversight processes that sponsors, especially smaller ones, must manage when working with multiple CROs and systems. By centralizing data, automating reporting, and providing sponsor-specific metrics, ClinOps Pro promises to give sponsors greater autonomy, control, and actionable insights, thereby reducing busywork and the need for additional headcount. Founded in 2018 and based in San Diego, the company operates in the Clinical Research and Digital Health sectors.

Clinical ResearchDigital Health

Technology Platform

ClinOps Pro: A cloud-based clinical operations workflow automation platform that uses AI and automation to aggregate data, standardize oversight, and provide sponsor-specific metrics and insights for clinical trials managed with CROs.

Opportunities

The growing reliance on CROs and the complexity of modern clinical trials create a strong, sustained demand for tools that give sponsors control and clarity.

Targeting the underserved small-to-mid-sized biotech segment, which is agile and growing rapidly, provides a clear beachhead for market entry and scale.

Risk Factors

Faces intense competition from large, entrenched clinical trial software suites.

Success depends on overcoming long sales cycles and integration challenges with diverse CRO systems.

As a private company, it carries execution risk in scaling sales and achieving profitability before exhausting funding.

Competitive Landscape

Competes against broad Clinical Trial Management Systems (CTMS) from Veeva, Medidata (a Dassault Systèmes company), and Oracle, as well as analytics and operational platforms from IQVIA and others. Differentiation lies in a focused, sponsor-centric design emphasizing ease of use, rapid deployment, and specific oversight workflows for sponsors using CROs.

More companies in Digital Health & Biotech SaaS →More companies in United States →